Leukemia driven by MLL-AF4 is extremely rare across all populations but represents a critical and poor-prognosis subtype within infant ALL.ALL driven by the MLL-AF4 fusion is exceptionally rare and particularly fulminant. This evidence concerns the gene KMT2A and leukemia.